Evidence map›Paper›PMID 41959557›Full record

ArticleFrontiers in cellular and infection microbiology2026

Genomic surveillance of the pneumonia outbreak caused by

Elena V Korneenko, Irina S Rog, Ivan K Chudinov, Anfisa I Kozyreva, Daria A Sandanova, Alexander V Pavlenko, Daria S Matyushkina, Vadim M Govorun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elena V Korneenko *Laboratory of Multiomics Research, Scientific Research Institute for Systems Biology and Medicine, Federal Service on Consumer Rights Protection and Human Well-Being Surveillance, Moscow, Russia.
Irina S Rog *Laboratory of Multiomics Research, Scientific Research Institute for Systems Biology and Medicine, Federal Service on Consumer Rights Protection and Human Well-Being Surveillance, Moscow, Russia.
Ivan K Chudinov *Laboratory of Multiomics Research, Scientific Research Institute for Systems Biology and Medicine, Federal Service on Consumer Rights Protection and Human Well-Being Surveillance, Moscow, Russia.
Anfisa I KozyrevaLaboratory of Multiomics Research, Scientific Research Institute for Systems Biology and Medicine, Federal Service on Consumer Rights Protection and Human Well-Being Surveillance, Moscow, Russia.
Daria A SandanovaLaboratory of Multiomics Research, Scientific Research Institute for Systems Biology and Medicine, Federal Service on Consumer Rights Protection and Human Well-Being Surveillance, Moscow, Russia.
Alexander V PavlenkoLaboratory of Mathematical Biology, Scientific Research Institute for Systems Biology and Medicine, Federal Service on Consumer Rights Protection and Human Well-Being Surveillance, Moscow, Russia.
Daria S MatyushkinaSymple Systems Laboratory, Scientific Research Institute for Systems Biology and Medicine, Federal Service on Consumer Rights Protection and Human Well-Being Surveillance, Moscow, Russia.
Vadim M GovorunLaboratory of Multiomics Research, Scientific Research Institute for Systems Biology and Medicine, Federal Service on Consumer Rights Protection and Human Well-Being Surveillance, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: MP, viral and bacterial co-infections were detected in 482 nasopharyngeal swabs from patients with CAP using real-time PCR method. To investigate the mutations associated with resistance to macrolides and quinolones we describe the development and usage of primer panels for the complete Results: MP was confirmed in 81.5% samples by real-time PCR and in 69.3% samples by ELISA. Bacterial co-infections were identified in 27.8% samples. Conclusion: This study demonstrates a fundamental shift in the epidemiology of MP in the post-COVID-19 era, characterized by a transition from cyclical epidemics to year-round endemic circulation. We document increased disease severity, a dynamic profile of viral and bacterial co-infections, and significant geographic heterogeneity in macrolide resistance rates, which ranged from 0% to 50% across regions. The overall macrolide resistance rate was 23%, which is lower than previously reported. Furthermore, genotyping of the complete P1 adhesin gene revealed divergence, with a majority of sequences clustering within P1 type 1 and a minority within P1 type 2.

Indexed as

Disease OutbreaksMycoplasma pneumoniaePneumonia, MycoplasmaAnti-Bacterial AgentsCoinfectionCommunity-Acquired PneumoniaDrug Resistance, BacterialFemaleHumansMacrolidesMutationQuinolonesRussiaAnti-Bacterial AgentsMacrolidesQuinolonesco-infectionscommunity-acquired pneumoniamacrolide resistanceMycoplasma pneumoniaeP1 adhesin

Identifiers

PMID41959557
PMCPMC13057555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.